Could a blood test replace a liver biopsy for diabetes patients?
NCT ID NCT04232293
Summary
This study aimed to see if two simple blood tests (called eLIFT and FibroMeter) could accurately screen for advanced liver scarring (fibrosis) in people with type 2 diabetes. It involved 722 participants with type 2 diabetes and a higher body weight. The results of the blood tests were compared to a special liver scan (FibroScan) and, in some cases, a liver biopsy, to see how well they worked.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 2 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHU d'Angers
Angers, 49100, France
-
CHU de Nantes
Nantes, 44093, France
Conditions
Explore the condition pages connected to this study.